Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 6, 2010, Pages 871-878

  Nanashima, Atsushi ^a   Tobinaga, Syuuichi ^a   Abo, Takafumi ^a   Nonaka, Takashi ^a   Takeshita, Hiroaki ^a   Hidaka, Shigekazu ^a   Sawai, Terumitsu ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Liver function; Liver resection; Posthepatectomy complications; Prognostic parameters

Indexed keywords

GALACTOSYL HUMAN SERUM ALBUMIN TC 99M; HYALURONIC ACID; INDOCYANINE GREEN; PROTHROMBIN; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; ASCITES; BILE DUCT CARCINOMA; BLEEDING; BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION TEST; LIVER LEVEL; LIVER METASTASIS; LIVER RESECTION; LIVER SCINTISCANNING; LIVER WEIGHT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROGNOSIS; RISK ASSESSMENT; TREATMENT INDICATION; COMPARATIVE STUDY; FOLLOW UP; INCIDENCE; JAPAN; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; PREOPERATIVE CARE; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; INCIDENCE; JAPAN; LIVER DISEASES; LIVER FAILURE; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 79952200211     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-010-0281-5     Document Type: Article

References (33)

1. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004;240:698-708.
2. Fan T, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg. 1999;229:322-30. (Pubitemid 30191766)
3. Miyagawa S, Makuuchi M, Kawasaki S, Kakazu T. Criteria for safe hepatic resection. Am J Surg. 1995;169:589-94.
4. Capussotti L, Viganò L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G. Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg. 2008;96:88-94.
5. Nanashima A, Yamaguchi H, Shibasaki S, Morino S, Ide N, Takeshita H, et al. Relationship between indocyanine green test and technetium-99m galactosyl serum albumin scintigraphy in patients scheduled for hepatectomy: clinical evaluation and patient outcome. Hepatol Res. 2004;28:184-90. (Pubitemid 38351912)
6. Nanashima A, Yamaguchi H, Tanaka K, Shibasaki S, Tsuji T, Ide N, et al. Preoperative serum hyaluronic acid level as a good predictor of posthepatectomy complications. Surg Today. 2004;34:913-9. (Pubitemid 40326468)
7. Nanashima A, Yamaguchi H, Morino S, Ide N, Takeshita H, Tsuji T, et al. Relationship between CT volumetry and functional liver volume using technetium-99m galactosyl serum albumin scintigraphy in patients undergoing preoperative portal vein embolization before major hepatectomy: a preliminary study. Dig Dis Sci. 2006;51:1190-5. (Pubitemid 44341518)
8. Hemming AW, Scudamore CH, Shackleton CR, Pudek M, Erb SR. Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg. 1992;163:515-8.
9. Ishigami Y, Masuzawa M, Miyoshi E, Kato M, Tamura K, Kanda M, et al. Clinical applications of ICG finger monitor in patients with liver disease. J Hepatol. 1993;19:232-40. (Pubitemid 23363030)
10. Mitsumori A, Nagaya I, Kimoto S, Akaki S, Togami I, Takeda Y, et al. Preoperative evaluation of hepatic functional reserve following hepatectomy by technetium-99m galactosyl human serum albumin liver scintigraphy and computed tomography. Eur J Nucl Med. 1998;25:1377-82. (Pubitemid 28464111)
11. Liver Cancer Study Group of Japan. Clinical and laboratory findings. In: Makuuchi M, editor. General rules for the clinical and pathological study of primary liver cancer, 2nd English edition. Tokyo: Kanehara & Co; 2003. p 13-28.
12. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-5. (Pubitemid 12218164)
13. Takasaki T, Kobayashi S, Suzuki S, Muto H, Marada M, Yamana Y, et al. Predetermining postoperative hepatic function for hepatectomies. Int Surg. 1980;65:309-13. (Pubitemid 12155191)
14. Kubota K, Makuuchi M, Kusaka K, Kobayashi T, Miki K, Hasegawa K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resection surgery for hepatic tumors. Hepatology. 1997;26:1176-81. (Pubitemid 27509300)
15. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 1990;107:521-7. (Pubitemid 20156653)
16. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304-9. (Pubitemid 29113766)
17. Yanaga K, Honda H, Ikeda Y, Nishizaki AT, Yamamoto K, Sugimachi K. Significance of liver size in hepatic surgery. HPB Surg. 1997;10:195-9.
18. Greenburg AG. Benefits and risks of blood transfusion in surgical patients. World J Surg. 1996;20:1189-93. (Pubitemid 26365680)
19. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005;242:824-8.
20. Befeler AS, Palmer DE, Hoffman M, Longo W, Solomon H, Di Bisceglie AM. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome. Arch Surg. 2005;140:650-4. (Pubitemid 41124001)
21. Eguchi S, Kamlot A, Ljubimova J, Hewitt WR, Lebow LT, Demetriou AA, et al. Fulminant hepatic failure in rats: survival and effect on blood chemistry and liver regeneration. Hepatology. 1996;24:1452-9. (Pubitemid 26399049)
22. Itasaka H, Suehiro T, Wakiyama S, Yanaga K, Shimada M, Sugimachi K. Significance of hyaluronic acid for evaluation of hepatic endothelial cell damage after cold preservation/reperfusion. J Surg Res. 1995;59:589-95.
23. Yachida S, Wakabayashi H, Kokudo Y, Goda F, Okada S, Maeba T, et al. Measurement of serum hyaluronate as a predictor of human liver failure after major hepatectomy. World J Surg. 2000;24:359-64. (Pubitemid 30117767)
24. Das BC, Isaji S, Kawarada Y. Analysis of 100 consecutive hepatectomies: risk factors in patients with liver cirrhosis or obstructive jaundice. World J Surg. 2001;25:266-72. (Pubitemid 32410361)
25. Kwon AH, Ha-Kawa SK, Uetsuji S, Inoue T, Matsui Y, Kamiyama Y. Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology. 1997;25:426-9. (Pubitemid 27069066)
26. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355-73. (Pubitemid 38388272)
27. Kawamura H, Kamiyama T, Nakagawa T, Nakanishi K, Yokoo H, Tahara M, et al. Preoperative evaluation of hepatic functional reserve by converted ICGR15 calculated from Tc-GSA scintigraphy. J Gastroenterol Hepatol. 2008;23:1235-41.
28. Fukui A, Murase K, Tsuda T, Fujii T, Ikezoe J. Assessment of liver function in chronic liver diseases and regional function of irradiated liver by means of 99mTc-galactosyl-human serum albumin liver scintigraphy and quantitative spectral analysis. Ann Nucl Med. 2000;14:467-76. (Pubitemid 32141384)
29. Yamanaka N, Okamoto E, Kuwata K, Tanaka N. A multiple regression equation for prediction of posthepatectomy liver failure. Ann Surg. 1984;200:658-63. (Pubitemid 15206049)
30. Uchiyama K, Mori K, Tabuse K, Ueno M, Ozawa S, Nakase T, et al. Assessment of liver function for successful hepatectomy in patients with hepatocellular carcinoma with impaired hepatic function. J Hepatobiliary Pancreat Surg. 2008;15:596-602.
31. Nagino M, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Sasaki R, et al. Logistic regression and discriminant analyses of hepatic failure after liver resection for carcinoma of the biliary tract. World J Surg. 1993;17:250-5. (Pubitemid 23120857)
32. Togo S, Matsuo K, Tanaka K, Matsumoto C, Shimizu T, Ueda M, et al. Perioperative infection control and its effectiveness in hepatectomy patients. J Gastroenterol Hepatol. 2007;22:1942-8. (Pubitemid 47525079)
33. Ishizawa T, Hasegawa K, Kokudo N, Sano K, Imamura H, Beck Y, et al. Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg. 2009;144:46-51.